# Remiazolam Combined With Esketamine in Painless Bidirectional Endoscopy in Children

> **NCT05686863** · NA · COMPLETED · sponsor: **Tongji Hospital** · enrollment: 106 (actual)

## Conditions studied

- Drug Effect

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Esketamine
- **DRUG:** Propofol
- **DRUG:** remifentanil

## Key facts

- **NCT ID:** NCT05686863
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-18
- **Primary completion:** 2023-07-07
- **Final completion:** 2023-07-07
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05686863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05686863, "Remiazolam Combined With Esketamine in Painless Bidirectional Endoscopy in Children". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05686863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*